Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Outskill Genai
    HomeNewsBusinessStocksBuy Sun Pharma; target of Rs 734: IIFL

    Buy Sun Pharma; target of Rs 734: IIFL

    IIFL is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 734 in its January 23, 2013 research report.

    January 23, 2013 / 13:26 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      IIFL is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 734 in its January 23, 2013 research report.
       
      “Sun Pharma had been moving in a downward channel between the range of Rs795 and Rs694 with decent volumes. We believe that the two week channel has matured and given a way to an upside breakout. In last two trading sessions, the stock has taken support at its 100-DMA, confirming the bullish set up. 100-DMA has acted as a solid line of support since December 2011. The daily RSI is suggesting strength in the upmove. (Duration 7 days),” says IIFL research report.


      Public holding more than 90% in Indian cos


      Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

      To read the full report click on the attachment

      Read More Read More

      first published: Jan 23, 2013 01:26 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347